Updates are available Correction dated 2019-11-29
Click to view Correction: https://doi.org/10.1038/s41598-019-54947-9
-
Authors
Heidt, Timo
Reiss, Simon
Krafft, Axel J.
Özen, Ali Caglar http://orcid.org/0000-0003-3536-0826
Lottner, Thomas
Hehrlein, Christoph
Galmbacher, Roland
Kayser, Gian
Hilgendorf, Ingo
Stachon, Peter
Wolf, Dennis
Zirlik, Andreas
Düring, Klaus
Zehender, Manfred
Meckel, Stephan http://orcid.org/0000-0001-6468-4526
von Elverfeldt, Dominik
Bode, Christoph
Bock, Michael http://orcid.org/0000-0001-9720-3506
von zur Mühlen, Constantin
-
Funding
Funding for this research was provided by:
European Society of Cardiology
ESC grant for medical research innovation
- License Information
-
More Information
Article History
Received: 2 October 2018
Accepted: 3 June 2019
First Online: 17 June 2019
Change Date: 29 November 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: Klaus Düring is shareholder and CEO of MaRVis Interventional GmbH. Michael Bock has a research agreement with Siemens Healthcare on development of imaging methods for MR-guided interventional procedures and MaRVis Interventional GmbH. All other authors declare no financial or non-financial conflicts of interest related to this manuscript.
